David S. Greenberg

Matters

Represented hundreds of health care providers in reimbursement litigation in federal court against the Defense Health Agency and the TRICARE program resulting in a 9-figure recovery.
Counseled an accountable care organization (ACO) in a $30 million contractual dispute with a national payor.
Defended a physician practice management company in federal court against a national health insurer alleging violations of the federal No Surprises Act.
Represented multiple physician practice management companies in arbitration concerning a $15 million contractual dispute with a health insurer.
Defended multiple pharmacies in a $25 million PBM audit.
Represented a hospital in a contractual dispute with a managed care plan concerning 340B reimbursement.
Defended multiple behavioral health companies in audits and investigations concerning compliance and billing practices.
Represented a dialysis company in a multi-million-dollar audit initiated by a PBM regarding pharmaceutical coverage under the Medicare program.
Resolved liability for durable medical equipment supplier through federal OIG health care fraud disclosure protocol.
Represented a national urgent care provider in a credentialing and reimbursement dispute with an insurer.
Defended a clinical laboratory in a multi-million-dollar reimbursement dispute against a Medicare Advantage plan.
Counseled a national physician practice company on fraud and abuse and compliance matters.
Developed and implemented the overhaul of the compliance program for a health care and social services agency.
Defended a medical device company in a special investigation unit (SIU) payor investigation and parallel US Department of Justice (DOJ) investigation.
Counseled a national home health company on regulatory, reimbursement, and compliance matters related to its participation in state Medicaid programs.
Conducted internal investigations on behalf of multiple skilled nursing facility chains concerning compliance with Medicare program billing and payment rules related to a False Claims Act investigation.
Drafted value-based managed care contracts for a disease management company.